4 years of revenue, earnings, cash-flow and balance-sheet history from public filings.
Qiagen N.V. (QGEN) operates in the Diagnostics & Research industry and is headquartered in Venlo, Netherlands with about 5,500 employees. Its market capitalization is roughly $8 billion. In the fiscal year ended 2025-12-31, QGEN reported $2.1B in revenue and $425M in net income.
Qiagen N.V. provides sample to insight solutions that transform biological samples into molecular insights worldwide.
Interactive charts & full statements → Open the QGEN valuation workbench →
| Income statement | 2025-12-31 | 2024-12-31 | 2023-12-31 | 2022-12-31 | 2021-12-31 |
|---|---|---|---|---|---|
| Total Revenue | $2.1B | $2.0B | $2.0B | $2.1B | — |
| Gross Profit | $1.3B | $967M | $1.2B | $1.4B | — |
| Operating Income (EBIT) | $520M | $200M | $445M | $576M | — |
| Net Income | $425M | $84M | $341M | $423M | — |
USD; $M / $B as marked. Newest period first. Source: public company filings (via Yahoo Finance aggregation).
| Quarterly income statement | 2026-03-31 | 2025-12-31 | 2025-09-30 | 2025-06-30 | 2025-03-31 |
|---|---|---|---|---|---|
| Total Revenue | $492M | $540M | $533M | $534M | $484M |
| Gross Profit | $310M | $325M | $331M | $334M | $309M |
| Operating Income (EBIT) | $117M | $122M | $137M | $136M | $125M |
| Net Income | $68M | $108M | $130M | $96M | $91M |
USD; $M / $B as marked. Newest period first. Source: public company filings (via Yahoo Finance aggregation).
| Cash flow | 2025-12-31 | 2024-12-31 | 2023-12-31 | 2022-12-31 | 2021-12-31 |
|---|---|---|---|---|---|
| Dividends Paid | ($54M) | $0M | $0M | — | — |
USD; $M / $B as marked. Newest period first. Source: public company filings (via Yahoo Finance aggregation).
| Quarterly cash flow | 2026-03-31 | 2025-12-31 | 2025-09-30 | 2025-06-30 | 2025-03-31 | 2024-12-31 |
|---|---|---|---|---|---|---|
| Dividends Paid | — | $0M | — | — | — | — |
USD; $M / $B as marked. Newest period first. Source: public company filings (via Yahoo Finance aggregation).
| Balance sheet | 2025-12-31 | 2024-12-31 | 2023-12-31 | 2022-12-31 | 2021-12-31 |
|---|---|---|---|---|---|
| Total Assets | $6.3B | $5.7B | $6.1B | $6.3B | — |
| Total Liabilities | $2.5B | $2.1B | $2.3B | $2.8B | — |
USD; $M / $B as marked. Newest period first. Source: public company filings (via Yahoo Finance aggregation).
Quarterly statements, profitability ratios, price history, insider activity and institutional holders are in the interactive QGEN viewer.
About TickerBase · Data methodology & sources